Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Hatami

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Life Sciences|June 28, 2023
Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosisSamaneh Siapoush, Ramazan Rezaei, Helia Alavifard, et al.
BMC Research Notes|July 16, 2025
Carbohydrate consumption and cirrhosis-related mortality: a prospective cohort studyNastaran Raissi-Dehkordi, Negar Raissi-Dehkordi, Azita Hekmatdoost, et al.
BMC Gastroenterology|July 3, 2023
Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort studyGhazal Daftari, Asal Neshatbini Tehrani, Fereshteh Pashayee-Khamene, et al.
Journal of Nutritional Science|November 21, 2022
Salt consumption and mortality risk in cirrhotic patients: results from a cohort studyFereshteh Pashayee-Khamene, Melika Hajimohammadebrahim-Ketabforoush, Mahdi Saber-Firoozi, et al.
Clinical Nutrition ESPEN|March 24, 2023
Malnutrition and its association with the mortality in liver cirrhosis; a prospective nutritional assessment in two referral centers in IranFereshteh Pashayee-Khamene, Melika Hajimohammadebrahim-Ketabforoush, Mohammad Amin Shahrbaf, et al.
European Journal of Clinical Nutrition|January 6, 2019
The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver diseaseSaeede Saadati, Behzad Hatami, Zahra Yari, et al.
Gastroenterology and Hepatology From Bed to Bench|March 8, 2018
Development of experimental fibrotic liver diseases animal model by Carbon TetracholorideAtoosa Gitiara, Samaneh Tokhanbigli, Sogol Mazhari, et al.
Tanaffos|December 2, 2016
Outcome of Acute Kidney Injury in Critical Care Unit, Based on AKI NetworkSeyed Mohammadreza Hashemian, Hamidreza Jamaati, Behrooz Farzanegan Bidgoli, et al.
Scientific Reports|November 23, 2023
Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisSara Abdollahiyan, Ali Nabavi-Rad, Shahrbanoo Keshavarz Azizi Raftar, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 6, 2025
Targeting inflammatory dysregulation in metabolic dysfunction-associated steatotic liver disease rat model: the preventive and therapeutic effects of acetyl-11-keto-beta-boswellic acidSajad Ehtiati, Roya Pakrad, Seyyed Hossein Khatami, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Life Sciences|June 28, 2023
Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosisSamaneh Siapoush, Ramazan Rezaei, Helia Alavifard, et al.
BMC Research Notes|July 16, 2025
Carbohydrate consumption and cirrhosis-related mortality: a prospective cohort studyNastaran Raissi-Dehkordi, Negar Raissi-Dehkordi, Azita Hekmatdoost, et al.
BMC Gastroenterology|July 3, 2023
Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort studyGhazal Daftari, Asal Neshatbini Tehrani, Fereshteh Pashayee-Khamene, et al.
Journal of Nutritional Science|November 21, 2022
Salt consumption and mortality risk in cirrhotic patients: results from a cohort studyFereshteh Pashayee-Khamene, Melika Hajimohammadebrahim-Ketabforoush, Mahdi Saber-Firoozi, et al.
Clinical Nutrition ESPEN|March 24, 2023
Malnutrition and its association with the mortality in liver cirrhosis; a prospective nutritional assessment in two referral centers in IranFereshteh Pashayee-Khamene, Melika Hajimohammadebrahim-Ketabforoush, Mohammad Amin Shahrbaf, et al.
European Journal of Clinical Nutrition|January 6, 2019
The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver diseaseSaeede Saadati, Behzad Hatami, Zahra Yari, et al.
Gastroenterology and Hepatology From Bed to Bench|March 8, 2018
Development of experimental fibrotic liver diseases animal model by Carbon TetracholorideAtoosa Gitiara, Samaneh Tokhanbigli, Sogol Mazhari, et al.
Tanaffos|December 2, 2016
Outcome of Acute Kidney Injury in Critical Care Unit, Based on AKI NetworkSeyed Mohammadreza Hashemian, Hamidreza Jamaati, Behrooz Farzanegan Bidgoli, et al.
Scientific Reports|November 23, 2023
Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisSara Abdollahiyan, Ali Nabavi-Rad, Shahrbanoo Keshavarz Azizi Raftar, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 6, 2025
Targeting inflammatory dysregulation in metabolic dysfunction-associated steatotic liver disease rat model: the preventive and therapeutic effects of acetyl-11-keto-beta-boswellic acidSajad Ehtiati, Roya Pakrad, Seyyed Hossein Khatami, et al.
Pageof 9